Alkem Laboratories clears USFDA inspection at Daman facility

29 Oct 2016 Evaluate

Alkem Laboratories has successfully cleared the inspection at Daman facility without any '483 observations'.  The United States Food and Drug Administration (USFDA) had conducted a Bio-analytical Inspection at the company’s manufacturing facility located at Daman, India from October 24 to October 28, 2016. The inspection has been cleared successfully without any 483 observations. This inspection was based on an ANDA filed by the company.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.


Alkem Laboratories Share Price

5419.75 -12.10 (-0.22%)
23-Dec-2024 10:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.75
Dr. Reddys Lab 1342.90
Cipla 1467.70
Lupin 2156.35
Zydus Lifesciences 968.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.